Shenzhen Neptunus Interlong Bio-Technique Company Limited (Stock Code: 08329) submitted a monthly return dated November 3, 2025, for the period ended October 31, 2025. The report indicates that the company’s authorized and issued share capital remained unchanged during the reporting period.

The announcement shows total authorized share capital of 426,000,000 H shares, each with a par value of RMB 0.1, amounting to RMB 42,600,000. The company continues to have 426,000,000 issued H shares and 1,252,000,000 domestic shares on record, with no increase, decrease, or repurchase activities noted. The report also confirms there were no outstanding or newly issued warrants, convertible instruments, share options, or other share issuance arrangements during the month.